BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16905120)

  • 1. Down-regulation of integrin alpha M beta 2 ligand-binding function by the urokinase-type plasminogen activator receptor.
    Tang ML; Kong LS; Law SK; Tan SM
    Biochem Biophys Res Commun; 2006 Sep; 348(3):1184-93. PubMed ID: 16905120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W; Mizukami I; Todd RF; Petty HR
    Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
    Kindzelskii AL; Laska ZO; Todd RF; Petty HR
    J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the influence of ectodomain affinities on the spatial distribution of membrane receptors.
    Weinand RG; Rosenspire AJ; Petty HR
    J Theor Biol; 1999 Mar; 197(2):217-25. PubMed ID: 10074395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.
    Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR
    J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
    Pliyev BK; Antonova OA; Menshikov M
    Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
    Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
    J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration.
    Pluskota E; Soloviev DA; Plow EF
    Blood; 2003 Feb; 101(4):1582-90. PubMed ID: 12393547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
    J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
    Chavakis T; Kanse SM; May AE; Preissner KT
    Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of urokinase receptor function and pericellular proteolysis by the integrin alpha(5)beta(1).
    Bass R; Ellis V
    Thromb Haemost; 2009 May; 101(5):954-62. PubMed ID: 19404550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule.
    Ragno P
    Cell Mol Life Sci; 2006 May; 63(9):1028-37. PubMed ID: 16465446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
    Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
    Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.
    Xue W; Kindzelskii AL; Todd RF; Petty HR
    J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive.
    Orchekowski RP; Plescia J; Altieri DC; Bajt ML
    J Leukoc Biol; 2000 Nov; 68(5):641-9. PubMed ID: 11073102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease crosstalk with integrins: the urokinase receptor paradigm.
    Chapman HA; Wei Y
    Thromb Haemost; 2001 Jul; 86(1):124-9. PubMed ID: 11486997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.
    Viswanathan K; Richardson J; Togonu-Bickersteth B; Dai E; Liu L; Vatsya P; Sun YM; Yu J; Munuswamy-Ramanujam G; Baker H; Lucas AR
    J Leukoc Biol; 2009 Mar; 85(3):418-26. PubMed ID: 19052145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.